ReviewCancer immunology, immunotherapy : CII2025
Biology and evolving management of resectable dMMR/MSI-H cancers: current status and future perspectives.
Tokiyoshi Tanegashima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it